We are live on ! Find out more
BIOA

BioAge Labs

144 hedge funds and large institutions have $599M invested in BioAge Labs in 2026 Q1 according to their latest regulatory filings, with 49 funds opening new positions, 46 increasing their positions, 27 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

188% more first-time investments, than exits

New positions opened: 49 | Existing positions closed: 17

91% more capital invested

Capital invested by funds: $314M → $599M (+$285M)

70% more repeat investments, than reductions

Existing positions increased: 46 | Existing positions reduced: 27

26% more funds holding

Funds holding: 114144 (+30)

11.27% more ownership

Funds ownership: 66%77.26% (+11%)

0% more funds holding in top 10

Funds holding in top 10: 66 (0)

85% less call options, than puts

Call options by funds: $283K | Put options by funds: $1.95M

Holders
144
Holders Change
+30
Holders Change %
+26.32%
% of All Funds
1.77%
Holding in Top 10
6
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.07%
New
49
Increased
46
Reduced
27
Closed
17
Calls
$283K
Puts
$1.95M
Net Calls
-$1.67M
Net Calls Change
-$2.38M
Name Holding Trade Value Shares
Change
Change in
Stake
AG
51
Algert Global
California
$1.12M -$2.54M -131,822 -67%
Russell Investments Group
52
Russell Investments Group
United Kingdom
$1.11M +$423K +21,948 +53%
SEI Investments
53
SEI Investments
Pennsylvania
$1.09M +$1.2M +62,385 New
Bank of America
54
Bank of America
North Carolina
$1.08M -$2.45M -127,175 -67%
TI
55
Trexquant Investment
Connecticut
$1.06M +$409K +21,238 +54%
Susquehanna International Group
56
Susquehanna International Group
Pennsylvania
$1.05M +$147K +7,650 +15%
DP
57
Diadema Partners
New Jersey
$1.05M -$4.07M -211,164 -78%
Ameriprise
58
Ameriprise
Minnesota
$1.03M -$459K -23,830 -29%
BCM
59
Bridgeway Capital Management
Texas
$1.01M -$385K -20,000 -26%
Squarepoint
60
Squarepoint
New York
$971K +$81.8K +4,247 +8%
SCM
61
Stonepine Capital Management
Oregon
$875K +$96.3K +5,000 +11%
SGM
62
Seven Grand Managers
New York
$875K +$963K +50,000 New
N
63
Nuveen
North Carolina
$852K +$345K +17,894 +58%
Two Sigma Investments
64
Two Sigma Investments
New York
$821K +$92.4K +4,800 +11%
XT
65
XTX Topco
Cayman Islands
$820K +$195K +10,151 +28%
Voloridge Investment Management
66
Voloridge Investment Management
Florida
$638K +$703K +36,506 New
RhumbLine Advisers
67
RhumbLine Advisers
Massachusetts
$618K +$112K +5,793 +20%
EI
68
EAM Investors
California
$609K +$670K +34,809 New
JF
69
Jump Financial
Illinois
$593K -$171K -8,900 -21%
Los Angeles Capital Management
70
Los Angeles Capital Management
California
$593K -$125K -6,489 -16%
MCM
71
Militia Capital Management
Texas
$565K +$622K +32,286 New
BNP Paribas Financial Markets
72
BNP Paribas Financial Markets
France
$552K -$1.55M -80,231 -72%
State of Wisconsin Investment Board
73
State of Wisconsin Investment Board
Wisconsin
$512K +$564K +29,302 New
American Century Companies
74
American Century Companies
Missouri
$506K +$557K +28,903 New
Barclays
75
Barclays
United Kingdom
$494K -$184K -9,540 -25%

BIOA Hedge Fund Activity: Q1 2026 in Review

144 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in BioAge Labs (BIOA) for Q1 2026, worth a combined $599M — up 91% from $314M a quarter earlier.

Buyers outnumbered sellers: 49 funds opened new BIOA positions and 17 closed out — a net gain of 32 holders — while 46 added to existing stakes and 27 trimmed.

The largest buyer was Janus Henderson Group, adding an estimated $32.4M. The largest seller was Adage Capital Partners, cutting an estimated $10.6M.

  • 144 institutional investors held BioAge Labs (BIOA) as of Q1 2026, up from 114 in Q4 2025.
  • Funds reported $599M of BioAge Labs stock for Q1 2026, up 91% quarter-over-quarter.
  • 49 funds opened new BioAge Labs positions in Q1 2026 and 17 closed out, a net change of +32 holders.
  • The largest BioAge Labs buyer in Q1 2026 was Janus Henderson Group, an estimated $32.4M added.
  • The largest BioAge Labs seller in Q1 2026 was Adage Capital Partners, an estimated $10.6M sold.

Based on aggregated 13F filings for Q1 2026.